INTEC PHARMA LTD. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 55 rows, 55 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-09-16: Reporting owner Sassi Nir; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-09-16: Reporting owner Linscott Walt Addison; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-09-16: Reporting owner Navon Nadav; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-07-15: Reporting owner Pomerantz Roger; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-09-16 | Sassi Nir Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.32 exercise price | 2020-09-18 | |
| 2020-09-16 | Linscott Walt Addison Officer (Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.32 exercise price | 2020-09-18 | |
| 2020-09-16 | Navon Nadav Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.32 exercise price | 2020-09-18 | |
| 2020-07-15 | Pomerantz Roger Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $0.31 exercise price | 2020-07-17 | |
| 2020-07-15 | Meckler Jeffrey A Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.31 exercise price | 2020-07-17 | |
| 2020-07-15 | MADDALUNA ANTHONY J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $0.31 exercise price | 2020-07-17 | |
| 2020-07-15 | Karah Hila Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $0.31 exercise price | 2020-07-17 | |
| 2020-07-15 | Hayes William B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $0.31 exercise price | 2020-07-17 | |
| 2020-07-15 | KOZARICH JOHN W Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $0.31 exercise price | 2020-07-17 | |
| 2020-02-17 | Sassi Nir Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $0.43 exercise price | 2020-02-19 | |
| 2020-02-17 | Navon Nadav Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $0.43 exercise price | 2020-02-19 | |
| 2020-02-17 | Linscott Walt Addison Officer (Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $0.43 exercise price | 2020-02-19 | |
| 2020-02-17 | GENDREAU R MICHAEL Officer (Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $0.43 exercise price | 2020-02-19 | |
| 2019-09-13 | Sassi Nir Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.90 exercise price | 2019-09-16 | |
| 2019-09-13 | Linscott Walt Addison Officer (Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.90 exercise price | 2019-09-16 | |
| 2019-06-28 | Silberman Issac Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.86 exercise price | 2019-07-02 | |
| 2019-06-28 | Pomerantz Roger Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.86 exercise price | 2019-07-02 | |
| 2019-06-28 | MADDALUNA ANTHONY J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.86 exercise price | 2019-07-02 | |
| 2019-06-28 | Karah Hila Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.86 exercise price | 2019-07-02 | |
| 2019-06-28 | Hayes William B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.86 exercise price | 2019-07-02 | |
| 2019-06-28 | Bianco Gil Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.86 exercise price | 2019-07-02 | |
| 2019-04-04 | Meckler Jeffrey A Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $7.64 exercise price | 2019-04-05 | |
| 2019-01-22 | GENDREAU R MICHAEL Officer (Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $7.63 exercise price | 2019-01-23 | |
| 2019-01-22 | Linscott Walt Addison Officer (Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $7.63 exercise price | 2019-01-23 | |
| 2019-01-22 | Navon Nadav Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $7.63 exercise price | 2019-01-23 | |
| 2019-01-22 | Sassi Nir Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $7.63 exercise price | 2019-01-23 | |
| 2019-01-02 holding as of filing | Hayes William B Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Linscott Walt Addison Officer (Chief Business Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $8.56 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Linscott Walt Addison Officer (Chief Business Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $8.56 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Pomerantz Roger Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Sassi Nir Officer (Chief Financial Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | no price filed | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Sassi Nir Officer (Chief Financial Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.14 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Sassi Nir Officer (Chief Financial Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.47 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Sassi Nir Officer (Chief Financial Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.46 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Sassi Nir Officer (Chief Financial Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.19 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Navon Nadav Officer (Chief Operating Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.14 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Navon Nadav Officer (Chief Operating Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.47 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Navon Nadav Officer (Chief Operating Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.46 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Navon Nadav Officer (Chief Operating Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.19 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | GENDREAU R MICHAEL Officer (Chief Medical Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.10 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | KOZARICH JOHN W Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.53 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Meckler Jeffrey A Director, Officer (Chief Executive Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.32 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Meckler Jeffrey A Director, Officer (Chief Executive Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.32 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Meckler Jeffrey A Director, Officer (Chief Executive Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.70 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Meckler Jeffrey A Director, Officer (Chief Executive Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Silberman Issac Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | no price filed | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Silberman Issac Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Silberman Issac Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bianco Gil Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | no price filed | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bianco Gil Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bianco Gil Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | MADDALUNA ANTHONY J Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Karah Hila Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | no price filed | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Karah Hila Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Karah Hila Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.44 exercise price | 2019-01-02 |